Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 455

Similar articles for PubMed (Select 19474467)

1.

Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy.

Gingelmaier A, Grubert TA, Kost BP, Setzer B, Lebrecht D, Mylonas I, Mueller-Hoecker J, Jeschke U, Hiedl S, Friese K, Walker UA.

Antivir Ther. 2009;14(3):331-8.

PMID:
19474467
2.

Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.

Divi RL, Leonard SL, Kuo MM, Nagashima K, Thamire C, St Claire MC, Wade NA, Walker VE, Poirier MC.

Environ Mol Mutagen. 2007 Apr-May;48(3-4):201-9.

PMID:
16538687
3.

Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.

Maagaard A, Holberg-Petersen M, Kvittingen EA, Sandvik L, Bruun JN.

HIV Med. 2006 Jan;7(1):53-8.

PMID:
16313293
4.

Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress.

Ross AC, Leong T, Avery A, Castillo-Duran M, Bonilla H, Lebrecht D, Walker UA, Storer N, Labbato D, Khaitan A, Tomanova-Soltys I, McComsey GA.

HIV Med. 2012 Feb;13(2):98-106. doi: 10.1111/j.1468-1293.2011.00945.x. Epub 2011 Nov 21.

5.

Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.

Maagaard A, Holberg-Petersen M, Kollberg G, Oldfors A, Sandvik L, Bruun JN.

Antivir Ther. 2006;11(5):601-8.

PMID:
16964828
6.

Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy.

Shiramizu B, Shikuma KM, Kamemoto L, Gerschenson M, Erdem G, Pinti M, Cossarizza A, Shikuma C.

J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):370-4.

PMID:
12640193
7.

Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.

Maagaard A, Holberg-Petersen M, Løvgården G, Holm M, Pettersen FO, Kvale D.

J Infect Dis. 2008 Nov 15;198(10):1474-81. doi: 10.1086/592713.

8.

Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants.

Côté HC, Raboud J, Bitnun A, Alimenti A, Money DM, Maan E, Costei A, Gadawski I, Diong C, Read S, Shen S, Harrigan PR, Burdge DR, King SM, Forbes JC.

J Infect Dis. 2008 Sep 15;198(6):851-9. doi: 10.1086/591253.

9.

Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.

Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, Metcalf C, Latham B, Mallal S.

AIDS. 2003 Jun 13;17(9):1329-38.

PMID:
12799554
10.

Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir.

Divi RL, Walker VE, Wade NA, Nagashima K, Seilkop SK, Adams ME, Nesel CJ, O'Neill JP, Abrams EJ, Poirier MC.

AIDS. 2004 Apr 30;18(7):1013-21.

PMID:
15096804
11.

Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.

Hernàndez S, Morén C, López M, Coll O, Cardellach F, Gratacós E, Miró O, Garrabou G.

AIDS. 2012 Feb 20;26(4):419-28. doi: 10.1097/QAD.0b013e32834f3232.

PMID:
22156962
12.

Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens.

Jones SP, Qazi N, Morelese J, Lebrecht D, Sutinen J, Yki-Jărvinen H, Back DJ, Pirmohamed M, Gazzard BG, Walker UA, Moyle GJ.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):565-72.

PMID:
16284533
13.

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

Negredo E, Miró O, Rodríguez-Santiago B, Garrabou G, Estany C, Masabeu A, Force L, Barrufet P, Cucurull J, Domingo P, Alonso-Villaverde C, Bonjoch A, Morén C, Pérez-Alvarez N, Clotet B; MULTINEKA Study Group.

Clin Infect Dis. 2009 Sep 15;49(6):892-900. doi: 10.1086/605440.

14.

Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy.

Côté HC, Magil AB, Harris M, Scarth BJ, Gadawski I, Wang N, Yu E, Yip B, Zalunardo N, Werb R, Hogg R, Harrigan PR, Montaner JS.

Antivir Ther. 2006;11(1):79-86.

PMID:
16518963
15.
16.

Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women.

López S, Coll O, Durban M, Hernàndez S, Vidal R, Suy A, Morén C, Casademont J, Cardellach F, Mataró D, Miró O, Garrabou G.

Antivir Ther. 2008;13(6):833-8.

PMID:
18839784
17.

Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.

Haugaard SB, Andersen O, Pedersen SB, Dela F, Richelsen B, Nielsen JO, Madsbad S, Iversen J.

J Med Virol. 2005 Sep;77(1):29-38.

PMID:
16032748
18.

Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.

McComsey GA, Kang M, Ross AC, Lebrecht D, Livingston E, Melvin A, Hitti J, Cohn SE, Walker UA; AIDS Clinical Trials Group A5084.

HIV Clin Trials. 2008 Mar-Apr;9(2):126-36. doi: 10.1310/hct0902-126.

19.

The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?

Martin F, Taylor GP.

J Antimicrob Chemother. 2009 Nov;64(5):895-900. doi: 10.1093/jac/dkp303. Epub 2009 Aug 25. Review.

20.

Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.

Poirier MC, Divi RL, Al-Harthi L, Olivero OA, Nguyen V, Walker B, Landay AL, Walker VE, Charurat M, Blattner WA; Women and Infants Transmission Study (WITS) Group.

J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):175-83.

PMID:
12794551
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk